Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Cassava Sciences
Biotech
Cassava cuts 3rd of staff in wake of phase 3 Alzheimer's fail
Cassava is laying off 10 employees—a third of its workforce—as the biotech seeks to conserve cash in the wake of the failure of its Alzheimer’s drug.
James Waldron
Jan 8, 2025 3:38am
Fierce Biotech's Rotten Tomatoes of 2024
Dec 16, 2024 3:00am
Cassava flunks phase 3 Alzheimer's test, stops 2nd trial
Nov 25, 2024 8:45am
Cassava pays $40M over allegedly misleading Alzheimer's update
Sep 27, 2024 9:20am
Cue Biopharma queues up J&J vet as CBO—Chutes & Ladders
Sep 13, 2024 8:30am
Chutes & Ladders—Gilead's Merdad Parsey goes, Cassava loses CEO
Jul 19, 2024 8:00am